Agalsidase beta Disease Interactions
There is 1 disease interaction with agalsidase beta.
Alpha-galactosidase A proteins (applies to agalsidase beta) cardiac function
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Heart Disease
Appropriate medical support measures should be readily available when administering alpha-galactosidase A enzyme replacement therapy (ERT) due to the potential for severe infusion-associated reactions. Compromised cardiac function may predispose patients to a higher risk of severe complications from infusion-associated reactions. Closely monitor patients with compromised cardiac function during administration of ERT.
Switch to professional interaction data
Agalsidase beta drug interactions
There are 5 drug interactions with agalsidase beta.
Report options
More about agalsidase beta
- agalsidase beta consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
Elfabrio
Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement treatment that may be used long-term ...
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.